"Hundreds of stunning images from black history, drawn from old negatives, have long been buried in the musty envelopes and crowded bins of the New York Times archives. None of them were published by The Times until now. Were the photos — or the people in them — not deemed newsworthy enough? Did the images not arrive in time for publication? Were they pushed aside by words here at an institution long known as the Gray Lady?... Every day during Black History Month, we will publish at least one of these photographs online, illuminating stories that were never told in our pages and others that have been mostly forgotten... Many of these photographs, and their stories, are equally intriguing. But the collection is far from comprehensive. There are gaps, for many reasons."
Issues and developments related to IP, AI, and OM. My Bloomsbury book "Ethics, Information, and Technology" will be published in January 2026 and includes chapters on IP, AI, OM, and other emerging technologies (IoT, drones, robots, autonomous vehicles, VR/AR). Preorders are available via this webpage: https://www.bloomsbury.com/us/ethics-information-and-technology-9781440856662/
Monday, February 1, 2016
Unpublished Black History; New York Times, 2/1/16
Rachel L. Swarns, Darcy Eveleigh, and Damien Cave, New York Times; Unpublished Black History:
Sunday, January 31, 2016
Five Charged in U.S. With Stealing Secrets From GlaxoSmithKline; Reuters via New York Times, 1/20/16
Reuters via New York Times; Five Charged in U.S. With Stealing Secrets From GlaxoSmithKline:
"Five people, including two former GlaxoSmithKline researchers, were charged with a scheme to steal trade secrets from the British drugmaker for potential sale in China, according to indictments announced by the U.S. Attorney's Office in Philadelphia on Wednesday. The indictments include charges of conspiracy to steal trade secrets, conspiracy to commit wire fraud, conspiracy to commit money laundering, theft of trade secrets, and wire fraud... The alleged conspirators established three corporations in China, all using the name Renopharma, to sell the stolen information that could be used to reproduce Glaxo products and drugs in development, to competitors in China, according to the complaint."
Saturday, January 30, 2016
Aaron Swartz and copyright wars in the Internet age; Boston Globe, 1/28/16
Hiawatha Bray, Boston Globe; Aaron Swartz and copyright wars in the Internet age:
"Swartz is a particularly tragic casualty of a conflict as old as the Gutenberg Bible. When copycats can easily republish the latest Charles Dickens novel or Adele CD, how will artists and publishers get paid? But laws to protect intellectual-property rights can cripple the free exchange of ideas. Justin Peters seems as helpless as the rest of us to resolve this dilemma. But in his lucid and witty new book, he ably sketches the contours of the dilemma... Peters places Swartz’s well-meant misdeeds in historical context, showing how this young man was one of many smart, ambitious combatants on both sides of the copyright wars.
"I can’t fault Peters’s sympathy for Swartz, and I share his opinion that the prosecutorial sledgehammer fell much too hard. But Peters seems a little too inclined to play the populist, sneering at the pro-copyright arguments of publishers. Yes, our current intellectual property statutes are absurdly restrictive. But apart from strong protections, how would artists and writers hope to make a decent living? The conundrum continues, with activists on both sides engaged in constant efforts to redraw the boundaries. Peters’s new book is an excellent survey of the battlefield, and a sobering memorial to its most tragic victim."
Friday, January 29, 2016
Academics Want You to Read Their Work for Free; Atlantic, 1/26/16
Jane C. Hu, Atlantic; Academics Want You to Read Their Work for Free:
"Whitaker, who founded two other Elsevier journals and has a combined 50 years of editorial experience with the company, came into his new position after he heard about the former Lingua board’s actions and contacted Elsevier to express his dismay. “I disagreed with just about everything they were doing,” he said. He came out of retirement to sign a new contract with Elsevier in early January, and has since recruited several interim editors. He says that he and his editorial staff have received a fair amount of animosity from Glossa supporters. But Whitaker stands firmly in favor of for-profit publishing; noting that publishers’ profits allow them to invest in new projects. (Elsevier gave Whitaker funds to found two new journals—Brain and Cognition and Brain and Language.) Plus, he says, profits ensure longevity. “That’s one of the many reasons I support the idea of a publisher that makes money,” he says. “Lingua will be here when I retire, and Lingua will be here when I die.” The fate of Cognition, meanwhile remains to be seen. Barner and Snedeker plan to submit their petition to Elsevier on Wednesday. “The battle has been taken from a very small region—linguistics—to a much larger one,” says Rooryck. Barner and Snedeker are staying silent about their long-term plans, but their request sends a clear message to publishers: Scientists are ready for change."
‘Let’s Play’ enters the public domain as USPTO kills Sony’s trademark attempt; Digital Trends, 1/29/16
Danny Cowan, Digital Trends; ‘Let’s Play’ enters the public domain as USPTO kills Sony’s trademark attempt:
"After reviewing the matter, the USPTO found that “Let’s Play” was part of a larger vernacular, and is therefore ineligible for trademark. The new decision all but ensures that Sony’s attempted trademark is dead in the water. The McArthur Law Firm takes credit for the revised decision, noting that it submitted “over 50 examples of how Let’s Play is generic and descriptive of video game streaming” in order to thwart Sony’s trademark attempt. “The gaming community spoke, and the USPTO listened!” the firm announced this week."
U.S. Patent and Trademark Office News, 1/28/16
U.S. Patent and Trademark Office News:
"A report issued today by the U.S. Department of Commerce recommends amendments to copyright law that would provide courts with both more guidance and greater flexibility in awarding statutory damages. In its "White Paper on Remixes, First Sale, and Statutory Damages," the Department’s Internet Policy Task Force (IPTF) sets forth its conclusions on three important copyright topics in the digital age: (1) the legal framework for the creation of remixes; (2) the relevance and scope of the “first sale doctrine;” and (3) the appropriate calibration of statutory damages in the contexts of individual file sharers and secondary liability for large-scale infringement. The White Paper recommends amending the Copyright Act to incorporate a list of factors for courts and juries to consider when determining the amount of a statutory damages award. In addition, it advises changes to remove a bar to eligibility for the Act’s “innocent infringer” provision, and to lessen the risk of excessive statutory damages in the context of non-willful secondary liability for online service providers... This new report follows up on issues first discussed in a 2013 IPTF Green Paper, "Copyright Policy, Creativity, and Innovation in the Digital Economy," and is the product of two sets of written comments and five public meetings and roundtables conducted through the following year. The IPTF is made up of representatives from the United States Patent and Trademark Office (USPTO), The National Telecommunications and Information Administration (NTIA) and other Commerce Department agencies. The White Paper and additional background information can be found online at: www.uspto.gov/copyright-white-paper-2016."
Thursday, January 28, 2016
Pass the Defend Trade Secrets Act; The Hill, 1/27/16
Sens. Orrin Hatch (R-Utah) and Chris Coons (D-Del.), The Hill; Pass the Defend Trade Secrets Act:
"Every year, industrial spies infiltrate American companies, stealing valuable trade secrets and leaking them to domestic competitors and corporations overseas. This crime cripples innovation and hampers economic growth, costing U.S. businesses billions of dollars each year. What’s worse, federal law does little to protect against this form of intellectual property theft. In fact, trade secrets are the only form of intellectual property lacking remedies under federal civil law. To safeguard American ingenuity and give companies the protections they deserve, Congress should act now to pass the Defend Trade Secrets Act, which we authored earlier this year. In addition to the billions of dollars in direct economic costs, trade secret theft also stifles innovation by deterring companies from investing in research and development. Consider the case of DuPont—the chemical company that invented the life-saving Kevlar body armor used by our service members. DuPont invested significant time and resources developing a Kevlar material strong enough to withstand the penetrating trauma of rifle rounds and grenade shrapnel. Because of the company’s efforts, DuPont has saved thousands of lives. But six years ago, a rogue employee leaked the manufacturing process of Kevlar to a rival company in South Korea, costing DuPont nearly $1 billion in economic losses. In an instant, the company’s comparative advantage—which it had earned after investing thousands of man-hours and millions of dollars—disappeared. Lacking a federal private right of action, DuPont executives were fortunate that the FBI was able to conduct a successful criminal investigation under the Economic Espionage Act. But the FBI lacks the resources to investigate the tens of thousand or more thefts that take place each year. Last year, in fact, the Department of Justice brought only 15 criminal cases for trade secret theft. The absence of a federal private right of action for trade secret misappropriation leaves American intellectual property vulnerable to theft and discourages research and innovation."
Subscribe to:
Posts (Atom)